FTSE All-Share
5.526,27
PKT
-75,33
PKT
-1,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.05.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 07.05.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 07.05.26 | Diageo Overweight | Barclays Capital | |
| 07.05.26 | HSBC Neutral | JP Morgan Chase & Co. | |
| 07.05.26 | Diageo Buy | Deutsche Bank AG | |
| 07.05.26 | HSBC Neutral | UBS AG | |
| 07.05.26 | Diageo Outperform | Bernstein Research | |
| 06.05.26 | National Grid Overweight | JP Morgan Chase & Co. | |
| 06.05.26 | Diageo Outperform | Bernstein Research | |
| 06.05.26 | Unilever Hold | Deutsche Bank AG | |
| 06.05.26 | Diageo Outperform | RBC Capital Markets | |
| 06.05.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 06.05.26 | Diageo Buy | Jefferies & Company Inc. | |
| 06.05.26 | HSBC Hold | Deutsche Bank AG | |
| 06.05.26 | Vodafone Group Buy | Deutsche Bank AG | |
| 06.05.26 | HSBC Neutral | UBS AG | |
| 06.05.26 | HSBC Buy | Goldman Sachs Group Inc. | |
| 05.05.26 | National Grid Outperform | Bernstein Research | |
| 05.05.26 | HSBC Sector Perform | RBC Capital Markets | |
| 05.05.26 | GSK Outperform | Bernstein Research | |
| 05.05.26 | Diageo Buy | Deutsche Bank AG | |
| 05.05.26 | Vodafone Group Overweight | Barclays Capital | |
| 05.05.26 | HSBC Overweight | Barclays Capital | |
| 05.05.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 05.05.26 | HSBC Hold | Jefferies & Company Inc. | |
| 05.05.26 | HSBC Neutral | JP Morgan Chase & Co. | |
| 04.05.26 | Unilever Overweight | Barclays Capital | |
| 04.05.26 | AstraZeneca Outperform | Bernstein Research | |
| 01.05.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 01.05.26 | London Stock Exchange (LSE) Buy | Deutsche Bank AG | |
| 01.05.26 | Unilever Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 30.04.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | Unilever Sector Perform | RBC Capital Markets | |
| 30.04.26 | Unilever Sector Perform | RBC Capital Markets | |
| 30.04.26 | GSK Hold | Deutsche Bank AG | |
| 30.04.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 30.04.26 | GSK Underweight | Barclays Capital |